Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	RNA polymerase II sequence-specific DNA-binding transcription factor recruiting activity	NANOGP8 NANOG	1.09e-04	4	86	2	GO:0001010
GeneOntologyCellularComponent	clathrin-coated endocytic vesicle membrane	FZD4 IGF2R EGF EGFR FZD5	2.08e-05	79	88	5	GO:0030669
GeneOntologyCellularComponent	clathrin-coated vesicle	FZD4 IGF2R VWF EGF EGFR FZD5 ASTN2	6.41e-05	237	88	7	GO:0030136
GeneOntologyCellularComponent	clathrin-coated endocytic vesicle	FZD4 IGF2R EGF EGFR FZD5	6.80e-05	101	88	5	GO:0045334
GeneOntologyCellularComponent	Rad51B-Rad51C-Rad51D-XRCC2 complex	RAD51C RAD51B	1.05e-04	4	88	2	GO:0033063
GeneOntologyCellularComponent	anchoring junction	FZD4 TRAF4 IGF2R PDLIM3 HMCN1 PDLIM1 EGFR ARHGAP31 FZD5 DUOX2 IGSF21 ITGB5 RPL8	2.15e-04	976	88	13	GO:0070161
GeneOntologyCellularComponent	multivesicular body, internal vesicle	EGFR PMEL	2.60e-04	6	88	2	GO:0097487
GeneOntologyCellularComponent	DNA recombinase mediator complex	RAD51C RAD51B	3.63e-04	7	88	2	GO:0033061
GeneOntologyCellularComponent	clathrin-coated vesicle membrane	FZD4 IGF2R EGF EGFR FZD5	3.94e-04	147	88	5	GO:0030665
GeneOntologyCellularComponent	coated vesicle	FZD4 IGF2R VWF EGF EGFR FZD5 ASTN2	8.14e-04	360	88	7	GO:0030135
Domain	VWC_out	NELL1 NELL2 FCGBP VWF MUC6	1.92e-08	19	85	5	SM00215
Domain	EGF	NELL1 NELL2 FCGBP EGF HMCN1 SLIT3 AGRN ITGB5 FBN3	1.22e-06	235	85	9	SM00181
Domain	VWF_dom	NELL1 NELL2 FCGBP VWF MUC6	1.29e-06	42	85	5	IPR001007
Domain	EGF_CA	NELL1 NELL2 EGF HMCN1 SLIT3 AGRN FBN3	1.38e-06	122	85	7	SM00179
Domain	EGF-like_Ca-bd_dom	NELL1 NELL2 EGF HMCN1 SLIT3 AGRN FBN3	1.54e-06	124	85	7	IPR001881
Domain	EGF_1	NELL1 NELL2 EGF HMCN1 SLIT3 ASTN2 AGRN ITGB5 FBN3	2.39e-06	255	85	9	PS00022
Domain	EGF_2	NELL1 NELL2 EGF HMCN1 SLIT3 ASTN2 AGRN ITGB5 FBN3	3.27e-06	265	85	9	PS01186
Domain	EGF_Ca-bd_CS	NELL1 NELL2 EGF HMCN1 SLIT3 FBN3	5.27e-06	97	85	6	IPR018097
Domain	EGF_CA	NELL1 NELL2 EGF HMCN1 SLIT3 FBN3	5.94e-06	99	85	6	PS01187
Domain	Growth_fac_rcpt_	NELL1 NELL2 EGF HMCN1 EGFR SLIT3 FBN3	7.09e-06	156	85	7	IPR009030
Domain	EGF-type_Asp/Asn_hydroxyl_site	NELL1 NELL2 EGF HMCN1 SLIT3 FBN3	8.81e-06	106	85	6	IPR000152
Domain	EGF_3	NELL1 NELL2 EGF HMCN1 SLIT3 ASTN2 AGRN FBN3	1.17e-05	235	85	8	PS50026
Domain	EGF-like_dom	NELL1 NELL2 FCGBP EGF HMCN1 SLIT3 AGRN FBN3	1.77e-05	249	85	8	IPR000742
Domain	TIL	FCGBP VWF MUC6	1.94e-05	12	85	3	PF01826
Domain	C8	FCGBP VWF MUC6	1.94e-05	12	85	3	PF08742
Domain	EGF	EGF HMCN1 SLIT3 AGRN ITGB5 FBN3	2.37e-05	126	85	6	PF00008
Domain	EGF-like_CS	NELL1 NELL2 EGF HMCN1 SLIT3 AGRN ITGB5 FBN3	2.48e-05	261	85	8	IPR013032
Domain	Unchr_dom_Cys-rich	FCGBP VWF MUC6	2.52e-05	13	85	3	IPR014853
Domain	C8	FCGBP VWF MUC6	2.52e-05	13	85	3	SM00832
Domain	VWC	NELL1 NELL2 FCGBP VWF	2.62e-05	38	85	4	SM00214
Domain	TIL_dom	FCGBP VWF MUC6	3.19e-05	14	85	3	IPR002919
Domain	EGF_CA	NELL1 NELL2 EGF HMCN1 FBN3	4.52e-05	86	85	5	PF07645
Domain	LamG	NELL1 NELL2 SLIT3 AGRN	4.72e-05	44	85	4	SM00282
Domain	VWD	FCGBP VWF MUC6	4.88e-05	16	85	3	SM00216
Domain	VWF_type-D	FCGBP VWF MUC6	4.88e-05	16	85	3	IPR001846
Domain	VWFD	FCGBP VWF MUC6	4.88e-05	16	85	3	PS51233
Domain	VWD	FCGBP VWF MUC6	4.88e-05	16	85	3	PF00094
Domain	ZM	PDLIM3 PDLIM1	6.12e-05	3	85	2	SM00735
Domain	Zasp-like_motif	PDLIM3 PDLIM1	6.12e-05	3	85	2	IPR006643
Domain	ASX_HYDROXYL	NELL1 NELL2 EGF HMCN1 FBN3	9.30e-05	100	85	5	PS00010
Domain	CT	VWF SLIT3 MUC6	1.32e-04	22	85	3	SM00041
Domain	Laminin_G	NELL1 NELL2 SLIT3 AGRN	1.41e-04	58	85	4	IPR001791
Domain	Cys_knot_C	VWF SLIT3 MUC6	1.95e-04	25	85	3	IPR006207
Domain	CTCK_2	VWF SLIT3 MUC6	1.95e-04	25	85	3	PS01225
Domain	VWC	NELL1 NELL2 VWF	2.74e-04	28	85	3	PF00093
Domain	DUF4749	PDLIM3 PDLIM1	3.03e-04	6	85	2	PF15936
Domain	Rad51_DMC1_RadA	RAD51C RAD51B	3.03e-04	6	85	2	IPR033925
Domain	DNA_recomb/repair_RecA-like	RAD51C RAD51B	3.03e-04	6	85	2	IPR016467
Domain	DUF4749	PDLIM3 PDLIM1	3.03e-04	6	85	2	IPR031847
Domain	DNA_recomb/repair_Rad51_C	RAD51C RAD51B	4.24e-04	7	85	2	IPR013632
Domain	Rad51	RAD51C RAD51B	4.24e-04	7	85	2	PF08423
Domain	RecA_ATP-bd	RAD51C RAD51B	4.24e-04	7	85	2	IPR020588
Domain	RECA_2	RAD51C RAD51B	4.24e-04	7	85	2	PS50162
Domain	VWFC_1	NELL1 NELL2 VWF	5.83e-04	36	85	3	PS01208
Domain	VWFC_2	NELL1 NELL2 VWF	6.84e-04	38	85	3	PS50184
Domain	Laminin_G_2	NELL1 NELL2 SLIT3	7.96e-04	40	85	3	PF02210
Domain	Znf_RING_CS	CBLL1 RNF144B TRAF4 RNF41 RBCK1	8.90e-04	163	85	5	IPR017907
Domain	-	NELL1 NELL2 SLIT3 AGRN	9.28e-04	95	85	4	2.60.120.200
Domain	Fol_N	FCGBP AGRN	1.10e-03	11	85	2	IPR003645
Domain	-	EGF HMCN1	1.10e-03	11	85	2	2.40.155.10
Domain	GFP-like	EGF HMCN1	1.10e-03	11	85	2	IPR023413
Domain	Frizzled	FZD4 FZD5	1.10e-03	11	85	2	IPR000539
Domain	Frizzled	FZD4 FZD5	1.10e-03	11	85	2	PF01534
Domain	FOLN	FCGBP AGRN	1.10e-03	11	85	2	SM00274
Domain	Frizzled	FZD4 FZD5	1.10e-03	11	85	2	SM01330
Domain	IBR	RNF144B RBCK1	1.80e-03	14	85	2	PF01485
Domain	-	TRAF4 RNF41	1.80e-03	14	85	2	3.90.890.10
Domain	IBR_dom	RNF144B RBCK1	2.07e-03	15	85	2	IPR002867
Domain	SIAH-type	TRAF4 RNF41	2.36e-03	16	85	2	IPR013323
Domain	Frizzled/SFRP	FZD4 FZD5	2.36e-03	16	85	2	IPR015526
Domain	GPCR_2-like	FZD4 FZD5 ADGRB2	2.58e-03	60	85	3	IPR017981
Domain	EGF_extracell	NELL1 NELL2 ITGB5	2.58e-03	60	85	3	IPR013111
Domain	EGF_2	NELL1 NELL2 ITGB5	2.58e-03	60	85	3	PF07974
Domain	G_PROTEIN_RECEP_F2_4	FZD4 FZD5 ADGRB2	2.71e-03	61	85	3	PS50261
Domain	TSP_1	HMCN1 ADGRB2 CFP	2.97e-03	63	85	3	PF00090
Domain	CTCK_1	VWF SLIT3	2.99e-03	18	85	2	PS01185
Domain	TSP1	HMCN1 ADGRB2 CFP	3.24e-03	65	85	3	SM00209
Domain	TSP1_rpt	HMCN1 ADGRB2 CFP	3.24e-03	65	85	3	IPR000884
Domain	TSP1	HMCN1 ADGRB2 CFP	3.24e-03	65	85	3	PS50092
Domain	FRI	FZD4 FZD5	3.69e-03	20	85	2	SM00063
Domain	-	FZD4 FZD5	4.06e-03	21	85	2	1.10.2000.10
Pathway	BIOCARTA_ERBB3_PATHWAY	EGF EGFR RNF41	1.77e-06	6	64	3	MM1543
Pathway	WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE	EGF EGFR GRM1	5.80e-05	17	64	3	M39564
Pathway	BIOCARTA_ERBB3_PATHWAY	EGF EGFR	2.01e-04	5	64	2	M22018
Pathway	REACTOME_DOWNREGULATION_OF_ERBB2_SIGNALING	EGF EGFR RNF41	2.15e-04	26	64	3	MM15501
Pathway	REACTOME_DOWNREGULATION_OF_ERBB2_SIGNALING	EGF EGFR RNF41	3.00e-04	29	64	3	M27756
Pathway	BIOCARTA_EEA1_PATHWAY	EGF EGFR	3.01e-04	6	64	2	MM1577
Pathway	BIOCARTA_EEA1_PATHWAY	EGF EGFR	4.20e-04	7	64	2	M22064
Pathway	KEGG_MEDICUS_REFERENCE_EGF_JAK_STAT_SIGNALING_PATHWAY	EGF EGFR	4.20e-04	7	64	2	M47430
Pathway	KEGG_MEDICUS_VARIANT_ERBB2_OVEREXPRESSION_TO_EGF_JAK_STAT_SIGNALING_PATHWAY	EGF EGFR	4.20e-04	7	64	2	M47431
Pathway	WP_FLUOROPYRIMIDINE_ACTIVITY	DPYD MTHFR TYMP	4.83e-04	34	64	3	M39612
Pathway	REACTOME_SIGNALING_BY_RNF43_MUTANTS	FZD4 FZD5	5.58e-04	8	64	2	M27433
Pathway	KEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY	EGF EGFR	5.58e-04	8	64	2	M47498
Pathway	KEGG_MEDICUS_REFERENCE_EGF_EGFR_PI3K_SIGNALING_PATHWAY	EGF EGFR	7.16e-04	9	64	2	M47392
Pathway	REACTOME_EGFR_INTERACTS_WITH_PHOSPHOLIPASE_C_GAMMA	EGF EGFR	7.16e-04	9	64	2	M27133
Pathway	REACTOME_EGFR_INTERACTS_WITH_PHOSPHOLIPASE_C_GAMMA	EGF EGFR	7.16e-04	9	64	2	MM14853
Pathway	WP_BLADDER_CANCER	EGF EGFR TYMP	7.82e-04	40	64	3	M39523
Pathway	REACTOME_REGULATION_OF_COMMISSURAL_AXON_PATHFINDING_BY_SLIT_AND_ROBO	NELL2 SLIT3	8.92e-04	10	64	2	M27348
Pathway	KEGG_BLADDER_CANCER	EGF EGFR TYMP	9.03e-04	42	64	3	M19096
Pathway	REACTOME_SIGNALING_BY_ERBB2	EGF EGFR RNF41	1.03e-03	44	64	3	MM14520
Pathway	BIOCARTA_CBL_PATHWAY	EGF EGFR	1.09e-03	11	64	2	MM1360
Pathway	BIOCARTA_EGFR_SMRTE_PATHWAY	EGF EGFR	1.09e-03	11	64	2	M18837
Pathway	KEGG_MEDICUS_REFERENCE_RAD51_DSDNA_DESTABILIZATION	RAD51C RAD51B	1.09e-03	11	64	2	M47894
Pathway	WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS	HK3 UGDH	1.09e-03	11	64	2	M48094
Pathway	BIOCARTA_EGFR_SMRTE_PATHWAY	EGF EGFR	1.09e-03	11	64	2	MM1432
Pathway	KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_RALGDS_SIGNALING_PATHWAY	EGF EGFR	1.09e-03	11	64	2	M47436
Pathway	KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_RASSF1_SIGNALING_PATHWAY	EGF EGFR	1.09e-03	11	64	2	M47432
Pathway	REACTOME_PYRIMIDINE_CATABOLISM	DPYD TYMP	1.09e-03	11	64	2	MM15423
Pathway	REACTOME_ERBB2_ACTIVATES_PTK6_SIGNALING	EGF EGFR	1.09e-03	11	64	2	MM15478
Pathway	WP_WNT_SIGNALING_PATHWAY_AND_PLURIPOTENCY	FZD4 NANOGP8 FZD5 NANOG	1.13e-03	101	64	4	MM15829
Pathway	REACTOME_CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS	FZD4 IGF2R EGF EGFR	1.18e-03	102	64	4	MM15498
Pathway	PID_A6B1_A6B4_INTEGRIN_PATHWAY	MST1 EGF EGFR	1.18e-03	46	64	3	M239
Pathway	BIOCARTA_KERATINOCYTE_PATHWAY	EGF EGFR MAP3K5	1.18e-03	46	64	3	M19118
Pathway	BIOCARTA_KERATINOCYTE_PATHWAY	EGF EGFR MAP3K5	1.18e-03	46	64	3	MM1428
Pathway	KEGG_MEDICUS_VARIANT_ERBB2_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY	EGF EGFR	1.30e-03	12	64	2	M47393
Pathway	BIOCARTA_CBL_PATHWAY	EGF EGFR	1.30e-03	12	64	2	M16973
Pathway	REACTOME_PYRIMIDINE_CATABOLISM	DPYD TYMP	1.30e-03	12	64	2	M10654
Pathway	REACTOME_CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS	FZD4 IGF2R EGF EGFR	1.31e-03	105	64	4	M27752
Pathway	PID_AJDISS_2PATHWAY	CBLL1 EGF EGFR	1.33e-03	48	64	3	M142
Pathway	WP_TROP2_REGULATORY_SIGNALING	IGF2R EGFR TACSTD2	1.42e-03	49	64	3	M46458
Pathway	REACTOME_SIGNALING_BY_ERBB2	EGF EGFR RNF41	1.50e-03	50	64	3	M553
Pathway	REACTOME_ERBB2_ACTIVATES_PTK6_SIGNALING	EGF EGFR	1.53e-03	13	64	2	M27729
Pathway	KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_JNK_SIGNALING_PATHWAY	EGF EGFR	1.53e-03	13	64	2	M47594
Pathway	REACTOME_ERBB2_REGULATES_CELL_MOTILITY	EGF EGFR	1.53e-03	13	64	2	MM15320
Pathway	REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING	EGF EGFR	1.53e-03	13	64	2	MM14701
Pathway	KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_SOST_LRP4	FZD4 FZD5	1.78e-03	14	64	2	M47834
Pathway	KEGG_MEDICUS_REFERENCE_EGF_EGFR_PI3K_NFKB_SIGNALING_PATHWAY	EGF EGFR	1.78e-03	14	64	2	M47536
Pathway	REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING	EGF EGFR	1.78e-03	14	64	2	M719
Pathway	REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING	EGF EGFR	1.78e-03	14	64	2	MM14761
Pathway	REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING	EGF EGFR	1.78e-03	14	64	2	MM14531
Pathway	WP_ESC_PLURIPOTENCY_PATHWAYS	FZD4 EGF EGFR FZD5	1.89e-03	116	64	4	MM15863
Pathway	WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS	FZD4 EGF EGFR FZD5	1.95e-03	117	64	4	M39530
Pathway	KEGG_MEDICUS_REFERENCE_RTK_PLCG_ITPR_SIGNALING_PATHWAY	MST1 EGF EGFR	1.98e-03	55	64	3	M47952
Pathway	PID_ERBB_NETWORK_PATHWAY	EGF EGFR	2.05e-03	15	64	2	M201
Pathway	REACTOME_CONSTITUTIVE_SIGNALING_BY_EGFRVIII	EGF EGFR	2.05e-03	15	64	2	M29701
Pathway	KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_PI3K_SIGNALING_PATHWAY	EGF EGFR	2.05e-03	15	64	2	M47389
Pathway	KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CAMK_SIGNALING_PATHWAY	EGF EGFR	2.05e-03	15	64	2	M47385
Pathway	KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_ERK_SIGNALING_PATHWAY	EGF EGFR	2.05e-03	15	64	2	M47382
Pathway	REACTOME_ERBB2_REGULATES_CELL_MOTILITY	EGF EGFR	2.05e-03	15	64	2	M27608
Pathway	KEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY	EGF EGFR	2.05e-03	15	64	2	M47495
Pathway	WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS	DPYD TYMP	2.05e-03	15	64	2	M39841
Pathway	KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_ERK_SIGNALING_PATHWAY	EGF EGFR	2.34e-03	16	64	2	M47363
Pathway	BIOCARTA_SPRY_PATHWAY	EGF EGFR	2.34e-03	16	64	2	MM1500
Pathway	KEGG_MEDICUS_REFERENCE_EGF_ERBB2_RAS_ERK_SIGNALING_PATHWAY	EGF EGFR	2.34e-03	16	64	2	M47381
Pathway	KEGG_MEDICUS_REFERENCE_WNT5A_ROR_SIGNALING_PATHWAY	FZD4 FZD5	2.34e-03	16	64	2	M47823
Pathway	REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING	EGF EGFR	2.34e-03	16	64	2	M562
Pathway	REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING	EGF EGFR	2.34e-03	16	64	2	M570
Pathway	REACTOME_SIGNALING_BY_ERBB2_ECD_MUTANTS	EGF EGFR	2.34e-03	16	64	2	M29847
Pathway	KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CALCINEURIN_SIGNALING_PATHWAY	EGF EGFR	2.34e-03	16	64	2	M47449
Pathway	BIOCARTA_SPRY_PATHWAY	EGF EGFR	2.64e-03	17	64	2	M1389
Pathway	REACTOME_GAB1_SIGNALOSOME	EGF EGFR	2.64e-03	17	64	2	MM14700
Pathway	REACTOME_GAB1_SIGNALOSOME	EGF EGFR	2.64e-03	17	64	2	M10450
Pathway	BIOCARTA_CARDIACEGF_PATHWAY	EGF EGFR	2.96e-03	18	64	2	M7552
Pathway	BIOCARTA_CARDIACEGF_PATHWAY	EGF EGFR	2.96e-03	18	64	2	MM1479
Pathway	KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_LGR_RSPO	FZD4 FZD5	3.30e-03	19	64	2	M47833
Pathway	REACTOME_SIGNALING_BY_NOTCH3	EGF EGFR	3.30e-03	19	64	2	MM15594
Pathway	REACTOME_CONSTITUTIVE_SIGNALING_BY_LIGAND_RESPONSIVE_EGFR_CANCER_VARIANTS	EGF EGFR	3.30e-03	19	64	2	M559
Pathway	BIOCARTA_MCALPAIN_PATHWAY	EGF EGFR	3.30e-03	19	64	2	MM1434
Pathway	BIOCARTA_MCALPAIN_PATHWAY	EGF EGFR	3.30e-03	19	64	2	M8719
Pathway	WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS	FZD4 EGFR FZD5	3.33e-03	66	64	3	M39642
Pathway	WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES	DPYD TYMP	3.66e-03	20	64	2	M39765
Pathway	REACTOME_REGULATION_OF_FZD_BY_UBIQUITINATION	FZD4 FZD5	3.66e-03	20	64	2	MM15155
Pathway	REACTOME_CLATHRIN_MEDIATED_ENDOCYTOSIS	FZD4 IGF2R EGF EGFR	3.93e-03	142	64	4	MM15499
Pathway	WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS	EGF EGFR	4.03e-03	21	64	2	M39735
Pathway	REACTOME_REGULATION_OF_FZD_BY_UBIQUITINATION	FZD4 FZD5	4.03e-03	21	64	2	M27401
Pathway	KEGG_MEDICUS_REFERENCE_EGF_EGFR_ACTIN_SIGNALING_PATHWAY	EGF EGFR	4.03e-03	21	64	2	M47722
Pathway	REACTOME_CLATHRIN_MEDIATED_ENDOCYTOSIS	FZD4 IGF2R EGF EGFR	4.23e-03	145	64	4	M27753
Pathway	REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING	EGF EGFR	4.42e-03	22	64	2	M26929
Pubmed	Toward a human blood serum proteome: analysis by multidimensional separation coupled with mass spectrometry.	HK3 EGFR ADGRB2 MAP3K5	1.51e-07	19	89	4	12543931
Pubmed	SNPs in genes coding for ROS metabolism and signalling in association with docetaxel clearance.	DPYD EGF EGFR	1.35e-06	9	89	3	20157331
Pubmed	Mga is essential for the survival of pluripotent cells during peri-implantation development.	NANOGP8 NANOG MGA	1.35e-06	9	89	3	25516968
Pubmed	High glucose promotes pancreatic cancer cell proliferation via the induction of EGF expression and transactivation of EGFR.	EGF EGFR	6.48e-06	2	89	2	22087246
Pubmed	Cholesterol levels modulate EGF receptor-mediated signaling by altering receptor function and trafficking.	EGF EGFR	6.48e-06	2	89	2	12162747
Pubmed	Ontogenesis and distribution of epidermal growth factor immunoreactivity and binding activity in the mouse fetal and neonatal tissues.	EGF EGFR	6.48e-06	2	89	2	7951532
Pubmed	Conformational stability of the epidermal growth factor (EGF) receptor as influenced by glycosylation, dimerization and EGF hormone binding.	EGF EGFR	6.48e-06	2	89	2	28019699
Pubmed	The role of EGF-EGFR signalling pathway in hepatocellular carcinoma inflammatory microenvironment.	EGF EGFR	6.48e-06	2	89	2	24268047
Pubmed	FRET detects lateral interaction between transmembrane domain of EGF receptor and ganglioside GM3 in lipid bilayers.	EGF EGFR	6.48e-06	2	89	2	33933428
Pubmed	pH dependence of ligand-induced human epidermal growth factor receptor activation investigated by molecular dynamics simulations.	EGF EGFR	6.48e-06	2	89	2	27179806
Pubmed	EGF ligand fused to truncated Pseudomonas aeruginosa exotoxin A specifically targets and inhibits EGFR‑positive cancer cells.	EGF EGFR	6.48e-06	2	89	2	30226622
Pubmed	The +61 A-G polymorphism of the epidermal growth factor gene is not associated with occurrence of non-melanocytic skin tumors in transplant recipients.	EGF EGFR	6.48e-06	2	89	2	17223314
Pubmed	Biochemical characterization and expression analysis of neural thrombospondin-1-like proteins NELL1 and NELL2.	NELL1 NELL2	6.48e-06	2	89	2	10548494
Pubmed	Epigenetic role of epidermal growth factor expression and signalling in embryonic mouse lung morphogenesis.	EGF EGFR	6.48e-06	2	89	2	1728582
Pubmed	Human adult epidermal melanocytes cultured without chemical mitogens express the EGF receptor and respond to EGF.	EGF EGFR	6.48e-06	2	89	2	17334773
Pubmed	Determining the geometry of oligomers of the human epidermal growth factor family on cells with <10 nm resolution.	EGF EGFR	6.48e-06	2	89	2	26009168
Pubmed	Functional effects of glycosylation at Asn-579 of the epidermal growth factor receptor.	EGF EGFR	6.48e-06	2	89	2	16274239
Pubmed	Association study between epidermal growth factor receptor and epidermal growth factor polymorphisms and endometriosis in a Japanese population.	EGF EGFR	6.48e-06	2	89	2	17852426
Pubmed	An association between EGF and EGFR gene polymorphisms with gastric cancer in a Chinese Han population.	EGF EGFR	6.48e-06	2	89	2	22534548
Pubmed	Epidermal growth factor as a biologic switch in hair growth cycle.	EGF EGFR	6.48e-06	2	89	2	12714603
Pubmed	Dynamic distribution of epidermal growth factor during mouse embryo peri-implantation.	EGF EGFR	6.48e-06	2	89	2	12967642
Pubmed	Engineered epidermal growth factor mutants with faster binding on-rates correlate with enhanced receptor activation.	EGF EGFR	6.48e-06	2	89	2	21439278
Pubmed	Functional evidence that the self-renewal gene NANOG regulates human tumor development.	NANOGP8 NANOG	6.48e-06	2	89	2	19415763
Pubmed	Functional independence of the epidermal growth factor receptor from a domain required for ligand-induced internalization and calcium regulation.	EGF EGFR	6.48e-06	2	89	2	2790960
Pubmed	Comparative analysis of thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in gastric and colorectal cancers.	DPYD TYMP	6.48e-06	2	89	2	15069545
Pubmed	Epidermal growth factor receptor (EGFR) signaling regulates global metabolic pathways in EGFR-mutated lung adenocarcinoma.	EGF EGFR	6.48e-06	2	89	2	24928511
Pubmed	Weak power frequency magnetic field acting similarly to EGF stimulation, induces acute activations of the EGFR sensitive actin cytoskeleton motility in human amniotic cells.	EGF EGFR	6.48e-06	2	89	2	24505297
Pubmed	Polyubiquitination of the epidermal growth factor receptor occurs at the plasma membrane upon ligand-induced activation.	EGF EGFR	6.48e-06	2	89	2	10788520
Pubmed	Structure-function analysis of Nel, a thrombospondin-1-like glycoprotein involved in neural development and functions.	NELL1 NELL2	6.48e-06	2	89	2	22157752
Pubmed	Biological and biochemical activities of a chimeric epidermal growth factor-Elk receptor tyrosine kinase.	EGF EGFR	6.48e-06	2	89	2	8413296
Pubmed	Clinical significance of EGF and EGFR expression changes in cryptorchid boys.	EGF EGFR	6.48e-06	2	89	2	12508124
Pubmed	Role of N-glycosylation in EGFR ectodomain ligand binding.	EGF EGFR	6.48e-06	2	89	2	28486782
Pubmed	Structural basis for inhibition of the epidermal growth factor receptor by cetuximab.	EGF EGFR	6.48e-06	2	89	2	15837620
Pubmed	Taiwan cobra cardiotoxin III suppresses EGF/EGFR-mediated epithelial-to-mesenchymal transition and invasion of human breast cancer MDA-MB-231 cells.	EGF EGFR	6.48e-06	2	89	2	26774845
Pubmed	EGF-liposomes promote efficient EGFR targeting in xenograft colocarcinoma model.	EGF EGFR	6.48e-06	2	89	2	26892017
Pubmed	Involvement of de novo synthesized palmitate and mitochondrial EGFR in EGF induced mitochondrial fusion of cancer cells.	EGF EGFR	6.48e-06	2	89	2	25483192
Pubmed	Alteration of the serum levels of the epidermal growth factor receptor and its ligands in patients with non-small cell lung cancer and head and neck carcinoma.	EGF EGFR	6.48e-06	2	89	2	17453000
Pubmed	Cell Force-Driven Basement Membrane Disruption Fuels EGF- and Stiffness-Induced Invasive Cell Dissemination from Benign Breast Gland Acini.	EGF EGFR	6.48e-06	2	89	2	33921304
Pubmed	FGFs in endochondral skeletal development.	EGF EGFR	6.48e-06	2	89	2	20564212
Pubmed	Heterogeneity in EGF-binding affinities arises from negative cooperativity in an aggregating system.	EGF EGFR	6.48e-06	2	89	2	18165319
Pubmed	Diminished salivary epidermal growth factor secretion: a link between Sjögren's syndrome and autoimmune gastritis?	EGF EGFR	6.48e-06	2	89	2	26399281
Pubmed	[Expression of epidermal growth factor receptor in patients with insulin resistance and seborrheic keratomas].	EGF EGFR	6.48e-06	2	89	2	28791994
Pubmed	Role of epidermal growth factor gene in the development of pancreatic cancer and efficiency of inhibitors of this gene in the treatment of pancreatic carcinoma.	EGF EGFR	6.48e-06	2	89	2	19110611
Pubmed	Effects of epidermal growth factor on preimplantation mouse embryos.	EGF EGFR	6.48e-06	2	89	2	9285326
Pubmed	EGF abrogation-induced fusilli-form dysmorphogenesis of Meckel's cartilage during embryonic mouse mandibular morphogenesis in vitro.	EGF EGFR	6.48e-06	2	89	2	8076525
Pubmed	Receptor overexpression or inhibition alters cell surface dynamics of EGF-EGFR interaction: new insights from real-time single molecule analysis.	EGF EGFR	6.48e-06	2	89	2	19014905
Pubmed	MASTL regulates EGFR signaling to impact pancreatic cancer progression.	EGFR MASTL	6.48e-06	2	89	2	34331012
Pubmed	Searching for EGF Fragments Recreating the Outer Sphere of the Growth Factor Involved in Receptor Interactions.	EGF EGFR	6.48e-06	2	89	2	38338748
Pubmed	Robust co-regulation of tyrosine phosphorylation sites on proteins reveals novel protein interactions.	PDLIM1 EGFR	6.48e-06	2	89	2	22851037
Pubmed	No association between epidermal growth factor and epidermal growth factor receptor polymorphisms and nasopharyngeal carcinoma.	EGF EGFR	6.48e-06	2	89	2	18722874
Pubmed	Expression and regulatory effects on cancer cell behavior of NELL1 and NELL2 in human renal cell carcinoma.	NELL1 NELL2	6.48e-06	2	89	2	25726761
Pubmed	Thymidine phosphorylase levels and dihydropyrimidine dehydrogenase levels in non-small cell lung cancer tissues.	DPYD TYMP	6.48e-06	2	89	2	16969493
Pubmed	Epidermal growth factor mutant with wild-type affinity for both ErbB1 and ErbB3.	EGF EGFR	6.48e-06	2	89	2	16584205
Pubmed	EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization.	EGF EGFR	6.48e-06	2	89	2	12620237
Pubmed	Potent SHC tyrosine phosphorylation by epidermal growth factor at low receptor density or in the absence of receptor autophosphorylation sites.	EGF EGFR	6.48e-06	2	89	2	8036006
Pubmed	Polymorphism in Sp1 recognition site of the EGF receptor gene promoter and risk of glioblastoma.	EGF EGFR	6.48e-06	2	89	2	16885506
Pubmed	Abnormal expression of epidermal growth factor and its receptor in the forebrain and serum of schizophrenic patients.	EGF EGFR	6.48e-06	2	89	2	12192610
Pubmed	B-vitamin intake, one-carbon metabolism, and survival in a population-based study of women with breast cancer.	MTHFR BHMT	6.48e-06	2	89	2	18708404
Pubmed	The epidermal growth factor.	EGF EGFR	6.48e-06	2	89	2	7640657
Pubmed	Shedding of soluble epidermal growth factor receptor (sEGFR) is mediated by a metalloprotease/fibronectin/integrin axis and inhibited by cetuximab.	EGF EGFR	6.48e-06	2	89	2	23731208
Pubmed	Maternal birth weight is associated with milk epidermal growth factor in Filipino women.	EGF EGFR	6.48e-06	2	89	2	32057154
Pubmed	The miR-200 family regulates the epithelial-mesenchymal transition induced by EGF/EGFR in anaplastic thyroid cancer cells.	EGF EGFR	6.48e-06	2	89	2	22797360
Pubmed	Detection of epidermal growth factor-urogastrone and its receptor during fetal mouse development.	EGF EGFR	6.48e-06	2	89	2	6248866
Pubmed	The distribution of epidermal growth factor binding sites in the developing mouse palate.	EGF EGFR	6.48e-06	2	89	2	8292539
Pubmed	DPYD*2A and MTHFR C677T predict toxicity and efficacy, respectively, in patients on chemotherapy with 5-fluorouracil for colorectal cancer.	DPYD MTHFR	6.48e-06	2	89	2	29134491
Pubmed	The neuronal EGF-related genes NELL1 and NELL2 are expressed in hemopoietic cells and developmentally regulated in the B lineage.	NELL1 NELL2	6.48e-06	2	89	2	10231576
Pubmed	Translocation of Epidermal Growth Factor (EGF) to the nucleus has distinct kinetics between adipose tissue-derived mesenchymal stem cells and a mesenchymal cancer cell lineage.	EGF EGFR	6.48e-06	2	89	2	29277356
Pubmed	Interaction of EGFR 497Arg>Lys with EGF +61A>G polymorphism: modulation of risk in esophageal cancer.	EGF EGFR	6.48e-06	2	89	2	18773861
Pubmed	Nucleic Acid Metabolizing Enzyme Levels Predict Chemotherapy Effects in Advanced and Recurrent Colorectal Cancer.	DPYD MTHFR	6.48e-06	2	89	2	35345374
Pubmed	EGF receptor-ligand interaction generates extracellular hydrogen peroxide that inhibits EGFR-associated protein tyrosine phosphatases.	EGF EGFR	6.48e-06	2	89	2	15982634
Pubmed	Heterodimerization of the epidermal-growth-factor (EGF) receptor and ErbB2 and the affinity of EGF binding are regulated by different mechanisms.	EGF EGFR	6.48e-06	2	89	2	11336639
Pubmed	Activation of epidermal growth factor receptor by epidermal growth factor.	EGF EGFR	6.48e-06	2	89	2	8639530
Pubmed	Association between epidermal growth factor (EGF) and EGF receptor gene polymorphisms and end-stage renal disease and acute renal allograft rejection in a Korean population.	EGF EGFR	6.48e-06	2	89	2	31906817
Pubmed	The intracellular juxtamembrane domain of the epidermal growth factor (EGF) receptor is responsible for the allosteric regulation of EGF binding.	EGF EGFR	6.48e-06	2	89	2	19336395
Pubmed	Complex relationship between ligand binding and dimerization in the epidermal growth factor receptor.	EGF EGFR	6.48e-06	2	89	2	25453753
Pubmed	EGF-dependent re-routing of vesicular recycling switches spontaneous phosphorylation suppression to EGFR signaling.	EGF EGFR	6.48e-06	2	89	2	26609808
Pubmed	[Expression of epidermal growth factor receptor and concentrations of epidermal growth factor and melatonin in endometrial carcinoma].	EGF EGFR	6.48e-06	2	89	2	25416211
Pubmed	Amplification of the EGFR gene can be maintained and modulated by variation of EGF concentrations in in vitro models of glioblastoma multiforme.	EGF EGFR	6.48e-06	2	89	2	28934307
Pubmed	Nanog1 in NTERA-2 and recombinant NanogP8 from somatic cancer cells adopt multiple protein conformations and migrate at multiple M.W species.	NANOGP8 NANOG	6.48e-06	2	89	2	24598770
Pubmed	Differential expression of nanog1 and nanogp8 in colon cancer cells.	NANOGP8 NANOG	6.48e-06	2	89	2	22079639
Pubmed	[TRAF4 promotes lung cancer development by activating tyrosine kinase of EGFR].	TRAF4 EGFR	6.48e-06	2	89	2	39414598
Pubmed	Palmitoylation of the EGF receptor impairs signal transduction and abolishes high-affinity ligand binding.	EGF EGFR	6.48e-06	2	89	2	19196031
Pubmed	Effect of epidermal growth factor administration on the development of mouse salivary gland carcinomas.	EGF EGFR	6.48e-06	2	89	2	9890455
Pubmed	Role of epidermal growth factor and its receptor in chemotherapy-induced intestinal injury.	EGF EGFR	6.48e-06	2	89	2	11841993
Pubmed	Simultaneous visualization of the extracellular and cytoplasmic domains of the epidermal growth factor receptor.	EGF EGFR	6.48e-06	2	89	2	21822280
Pubmed	Cloning and characterization of two novel human cDNAs (NELL1 and NELL2) encoding proteins with six EGF-like repeats.	NELL1 NELL2	6.48e-06	2	89	2	8975702
Pubmed	Proteome mapping of epidermal growth factor induced hepatocellular carcinomas identifies novel cell metabolism targets and mitogen activated protein kinase signalling events.	EGF EGFR	6.48e-06	2	89	2	25872475
Pubmed	Betaine rescue of an animal model with methylenetetrahydrofolate reductase deficiency.	MTHFR BHMT	6.48e-06	2	89	2	15217352
Pubmed	EGF signalling amplification induced by dynamic clustering of EGFR.	EGF EGFR	6.48e-06	2	89	2	15485674
Pubmed	EGF/EGFR axis contributes to the progression of cholangiocarcinoma through the induction of an epithelial-mesenchymal transition.	EGF EGFR	6.48e-06	2	89	2	24704591
Pubmed	Genetic variations in EGF and EGFR and glioblastoma outcome.	EGF EGFR	6.48e-06	2	89	2	20197289
Pubmed	EGF/EGFR Promotes Salivary Adenoid Cystic Carcinoma Cell Malignant Neural Invasion via Activation of PI3K/AKT and MEK/ERK Signaling.	EGF EGFR	6.48e-06	2	89	2	35410600
Pubmed	Sustained epidermal growth factor receptor levels and activation by tethered ligand binding enhances osteogenic differentiation of multi-potent marrow stromal cells.	EGF EGFR	6.48e-06	2	89	2	19544388
Pubmed	Association of epidermal growth factor and epidermal growth factor receptor polymorphisms with the risk of hepatitis B virus-related hepatocellular carcinoma in the population of North China.	EGF EGFR	6.48e-06	2	89	2	23790025
Pubmed	EGFR genomic gain and aberrant pathway signaling in pancreatic cancer patients.	EGF EGFR	6.48e-06	2	89	2	17950068
Pubmed	Expression of EGF, EGFR, and proliferation in placentas from pregnancies complicated with preeclampsia.	EGF EGFR	6.48e-06	2	89	2	27657362
Pubmed	TRAF4 binds to the juxtamembrane region of EGFR directly and promotes kinase activation.	TRAF4 EGFR	6.48e-06	2	89	2	30352854
Pubmed	Impact of epidermal growth factor single-nucleotide polymorphism on recurrence of hepatocellular carcinoma after hepatectomy in patients with chronic hepatitis C virus infection.	EGF EGFR	6.48e-06	2	89	2	24703510
Pubmed	Expression of NANOG and NANOGP8 in a variety of undifferentiated and differentiated human cells.	NANOGP8 NANOG	6.48e-06	2	89	2	21136380
Pubmed	Modulation of focal adhesion constituents and their down-stream events by EGF: On the cross-talk of integrins and growth factor receptors.	EGF EGFR	6.48e-06	2	89	2	26079101
GeneFamily	G protein-coupled receptors, Class F frizzled	FZD4 FZD5	5.27e-04	11	57	2	286
Coexpression	NABA_ECM_GLYCOPROTEINS	NELL1 NELL2 VWF HMCN1 SLIT3 AGRN FBN3	4.82e-06	196	89	7	M3008
Coexpression	GSE12845_NAIVE_VS_PRE_GC_TONSIL_BCELL_UP	NELL2 EGF MOB3B AKAP13 LYST RPL8 MAP3K5	5.15e-06	198	89	7	M3198
Coexpression	GSE3982_DC_VS_MAC_LPS_STIM_UP	NELL2 CFP SIGLEC1 MGA TACSTD2 CBR3 SEC14L1	5.50e-06	200	89	7	M5387
Coexpression	HE_LIM_SUN_FETAL_LUNG_C0_MID_MESOTHELIAL_CELL	MST1 NELL2 MTHFR FAM221A ADGRB2 ARHGAP29 CARD16 ALDH1A3 LYST AGRN ITGB5 FBN3 SEC14L1	1.99e-05	955	89	13	M45680
Coexpression	MURARO_PANCREAS_ACINAR_CELL	TRAF4 PDLIM1 EGFR ANO6 FZD5 UGDH MOB3B DUOX2 TACSTD2 CHAC1 MAP3K5	3.78e-05	732	89	11	M39174
Coexpression	GAO_LARGE_INTESTINE_24W_C2_MKI67POS_PROGENITOR	FZD4 VWF HMCN1 ARHGAP29 SEC14L1	4.24e-05	113	89	5	M39153
Coexpression	NABA_CORE_MATRISOME	NELL1 NELL2 VWF HMCN1 SLIT3 AGRN FBN3	4.29e-05	275	89	7	M5884
Coexpression	NABA_ECM_GLYCOPROTEINS	NELL1 NELL2 VWF HMCN1 SLIT3 AGRN	4.87e-05	191	89	6	MM17059
Coexpression	GSE40274_IRF4_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	HK3 DUOX2 TACSTD2 ITGB5 CHAC1	5.21e-05	118	89	5	M9155
Coexpression	GSE7460_CTRL_VS_TGFB_TREATED_ACT_TCONV_UP	KCNQ5 FZD5 ARHGAP29 MOB3B LYST BHMT	6.11e-05	199	89	6	M5694
Coexpression	GSE17186_BLOOD_VS_CORD_BLOOD_CD21HIGH_TRANSITIONAL_BCELL_UP	MST1 MIS18BP1 HK3 ALMS1 MOB3B CBR3	6.29e-05	200	89	6	M7185
Coexpression	GSE40274_FOXP3_VS_FOXP3_AND_PBX1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	MST1 KCNQ5 ARHGAP31 FZD5 MYT1 ADGRB2	6.29e-05	200	89	6	M9181
Coexpression	FISCHER_DIRECT_P53_TARGETS_META_ANALYSIS	RAD51C RNF144B TRAF4 ASTN2 TNFRSF10D ALDH1A3 DNAI3	9.28e-05	311	89	7	M61
Coexpression	HE_LIM_SUN_FETAL_LUNG_C7_COL20A1_POS_SCHWANN_CELL	HMCN1 PDLIM1 ARHGAP31 ALDH1A3	1.07e-04	72	89	4	M45791
Coexpression	GSE12484_HEALTHY_VS_PERIDONTITIS_NEUTROPHILS_UP	NELL1 EGF ARHGAP29 MFSD2B CSMD2	1.13e-04	139	89	5	M433
Coexpression	DELYS_THYROID_CANCER_UP	DPYD NELL2 PDLIM1 ALDH1A3 TACSTD2 AGRN ITGB5 MAP3K5	1.38e-04	445	89	8	M3645
Coexpression	ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_UP	PARP10 HK3 ARHGAP31 MASTL CFP CARD16 SIGLEC1 TYMP LYST AGRN RBCK1 SEC14L1	1.58e-04	1012	89	12	M40868
Coexpression	HUANG_DASATINIB_SENSITIVITY_UP	DPYD EGFR ARHGAP29 DENND2B	1.61e-04	80	89	4	M3015
ToppCell	proximal-Hematologic-Nonclassical_Monocyte-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	RNF144B MIS18BP1 HK3 CFP CARD16 TYMP LYST MUC6	5.87e-09	196	89	8	7e136975e5943d42d51d8cc91c912547ef79cf4d
ToppCell	proximal-3-Hematologic-Nonclassical_Monocyte\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	RNF144B MIS18BP1 HK3 CFP CARD16 TYMP LYST MUC6	5.87e-09	196	89	8	e426d02c6bcff2358a45e627cc86389070a4af25
ToppCell	proximal-Hematologic-Nonclassical_Monocyte\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	RNF144B MIS18BP1 HK3 CFP CARD16 TYMP LYST MUC6	5.87e-09	196	89	8	439d695526714772971fd1a4a92b8b6a84eee1a4
ToppCell	COVID-19-lung-Macrophage_VCANhi_FCN1hi\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PROK2 RNF144B DPYD HK3 CFP SIGLEC1 TYMP	1.46e-07	198	89	7	ea34096bee852a7e996f097fa279381afa8f86ff
ToppCell	Neuronal-Excitatory\|Neuronal / cells hierarchy compared to all cells using T-Statistic	NELL1 DPYD NELL2 KCNQ5 SLIT3 AKAP13 GRM1	1.56e-07	200	89	7	4409065bc7aa995354c71e0f9d6f3726cf393d6b
ToppCell	(61)_LYVE1_Macrophage\|World / shred on Cell_type and subtype	NELL1 NELL2 HK3 CFP SIGLEC1 IGSF21 ITGB5	1.91e-07	206	89	7	711e961a9a03bfd2f0958bd14f25f7f207a2f2b5
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Penk_Fst\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	NELL2 PDLIM1 ARHGAP31 SLIT3 AKAP13 IGSF21	1.46e-06	176	89	6	a1b9f8f199a028b3fa85de43fe96bc29f387bfd8
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	NELL1 DPYD NELL2 SLIT3 GRM1 IGSF21	1.77e-06	182	89	6	35b2a5625323bf0917214d3b82fafc4a8f5e75ff
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	NELL1 DPYD NELL2 SLIT3 GRM1 IGSF21	1.89e-06	184	89	6	9a185e6ea86bbfbb48bfe88650a8c05ceba78d7f
ToppCell	Control-Endothelial_cells-Endothelial_cells_(general)\|Control / group, cell type (main and fine annotations)	FZD4 RNF144B VWF ARHGAP31 ARHGAP29 SEC14L1	2.08e-06	187	89	6	fb5bcbc8effdbf0e57fcb71aca990a4aa0d65ce8
ToppCell	COPD-Epithelial-Mesothelial\|COPD / Disease state, Lineage and Cell class	MST1 PDLIM3 EGFR SLIT3 UGDH ALDH1A3	2.21e-06	189	89	6	79bb2593ad5d17f94b17972884241f03a0f43770
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	NELL1 DPYD NELL2 KCNQ5 SLIT3 GRM1	2.21e-06	189	89	6	a75226616340045b581d08429d2e123e041dee55
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NELL1 SLIT3 MOB3B ALDH1A3 DNAI3 MAP3K5	2.28e-06	190	89	6	45df8fee00f8949937863159d7aa042e72748d9b
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-oligodendrocyte_precursor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NELL2 TRAF4 MYT1 UGDH PMEL IGSF21	2.28e-06	190	89	6	9b825b2586c7b173ff27fcf2abc5860faf50984a
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-Oligodendrocyte_progenitor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NELL2 TRAF4 MYT1 UGDH PMEL IGSF21	2.28e-06	190	89	6	d146af1926474328a7c822bc140c4dda66e1bbfb
ToppCell	RA-09._Endothelium_I\|World / Chamber and Cluster_Paper	RNF144B VWF ARHGAP31 ARHGAP29 TNFRSF10D SEC14L1	2.35e-06	191	89	6	c8a0c2af119bc34a8f694a7d30642f28002c84b9
ToppCell	droplet-Heart-nan-18m-Endothelial-endocardial_endothelial_cells\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MST1 IGF2R VWF PDLIM3 HMCN1 ASTN2	2.42e-06	192	89	6	0b9b2eaed45456d7d74ce78a64ef4a26ac2458fb
ToppCell	3'-Distal_airway-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RNF144B HK3 CFP CARD16 TYMP LYST	2.49e-06	193	89	6	cb0fb21510124883e716780bea46575620c366b8
ToppCell	RA-08._Macrophage\|World / Chamber and Cluster_Paper	RNF144B DPYD HK3 TYMP IGSF21 MUC6	2.49e-06	193	89	6	5fd22db1825d105709fcc0aa4955c99a117e3c82
ToppCell	3'-Distal_airway-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RNF144B HK3 CFP CARD16 TYMP LYST	2.49e-06	193	89	6	0c207879f994c227dcd1322faa69ec9e3749cdaa
ToppCell	wk_20-22-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_1\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	PDLIM3 HMCN1 PDLIM1 ANO6 SLIT3 TLCD5	2.49e-06	193	89	6	ba6eb29478d16589172f48f9992e5116328c81d6
ToppCell	3'-Distal_airway-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RNF144B HK3 CFP CARD16 TYMP LYST	2.49e-06	193	89	6	0fbbfcc803edc3cd96b35467ad5cc573af07fd67
ToppCell	RV-09._Endothelium_I\|World / Chamber and Cluster_Paper	RNF144B VWF HMCN1 ARHGAP31 ARHGAP29 SEC14L1	2.49e-06	193	89	6	e3fa47e2c7cd8a5b69186711c57751f2296de8ae
ToppCell	nucseq-Immune-Immune_Myeloid-pMON-pMON\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	RNF144B HK3 CFP TYMP LYST SEC14L1	2.57e-06	194	89	6	e237384b02be460d44eeada3026a5691c66f6fc1
ToppCell	10x5'v1-week_17-19-Myeloid_neutrophil-granulo-neutrophil-neutrophil\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	PROK2 IGF2R HK3 CARD16 TYMP LYST	2.57e-06	194	89	6	e2d0dfb92356fa7ad7008aa8ac4198e2ac5d2495
ToppCell	ILEUM-inflamed-(3)_mature_DC\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	RNF144B NELL2 MTHFR CFP TYMP LYST	2.57e-06	194	89	6	369bbf4e8e2d674e5a51a614b52b97d05d3ab9c7
ToppCell	nucseq-Immune-Immune_Myeloid-pMON\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	RNF144B HK3 CFP TYMP LYST SEC14L1	2.57e-06	194	89	6	0bc83ae79873a5e473e6e1e3111924cd003986a1
ToppCell	LA-08._Macrophage\|World / Chamber and Cluster_Paper	RNF144B DPYD SIGLEC1 TYMP IGSF21 MUC6	2.57e-06	194	89	6	c1805572bcc11b1cd29083329d7b5911489fb758
ToppCell	PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_1\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	DPYD HK3 CFP SIGLEC1 TYMP LYST	2.57e-06	194	89	6	885355ebe98e974f841cc59dce3b5228c642c5d0
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibro-meso-mesothelial_cell-Mesothelium-Mesothelium_L.2.6.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MST1 NELL1 PDLIM3 SLIT3 ALDH1A3 CHAC1	2.57e-06	194	89	6	421344cc4b601d9745fa72d0af3124dab11d1d27
ToppCell	RA-08._Macrophage\|RA / Chamber and Cluster_Paper	RNF144B DPYD SIGLEC1 TYMP IGSF21 MUC6	2.57e-06	194	89	6	ac26e5c71d5069622de72fa25a9c920887ac2c19
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Non-classical_Monocyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RNF144B DPYD MIS18BP1 HK3 CFP LYST	2.64e-06	195	89	6	1d58585557bf8e9ce4d514e128d3a902b526331d
ToppCell	LA-09._Endothelium_I\|World / Chamber and Cluster_Paper	RNF144B VWF HMCN1 ARHGAP31 ARHGAP29 SEC14L1	2.64e-06	195	89	6	fc95457a298b5d0dab687d9ee7e225a7f7b9a0d4
ToppCell	COVID-19-Myeloid-Monocyte-derived_macrophages\|COVID-19 / group, cell type (main and fine annotations)	RNF144B DPYD MOB3B SIGLEC1 TYMP IGSF21	2.64e-06	195	89	6	c172c5599379c29123340621a36bfb1fc90c2115
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-DC-cDC2\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	RNF144B SLIT3 AKAP13 CFP TYMP TACSTD2	2.64e-06	195	89	6	9c6bed8414633813e1655bbeaab682fb296958a9
ToppCell	LA-08._Macrophage\|LA / Chamber and Cluster_Paper	RNF144B DPYD SIGLEC1 TYMP IGSF21 MUC6	2.64e-06	195	89	6	5e1d5bdb8874091f5a2b1d0a8cc9008165718a97
ToppCell	LV-09._Endothelium_I\|World / Chamber and Cluster_Paper	RNF144B VWF HMCN1 ARHGAP31 ARHGAP29 SEC14L1	2.64e-06	195	89	6	19e0a6c3eae1615aaa39767300acd937dfcb2a7f
ToppCell	10x5'-blood-Myeloid_Monocytic-Nonclassical_monocytes\|blood / Manually curated celltypes from each tissue	RNF144B HK3 ARHGAP29 CFP CARD16 TYMP	2.64e-06	195	89	6	88d65c7c3a28922c125bd9f7c403a55d7d4d83a9
ToppCell	control-Non-classical_Monocyte\|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	RNF144B HK3 CFP CARD16 TYMP LYST	2.72e-06	196	89	6	1d71a5be652dd3281aba4f984f6ef84c993c5f63
ToppCell	(7)_Macrophage\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	RNF144B NELL1 CFP TYMP IGSF21 ITGB5	2.72e-06	196	89	6	f1c822860d2a0bae84b0263b0151185756423e0f
ToppCell	COVID-19-lung-Macrophage_VCANhi_FCN1hi\|lung / Disease (COVID-19 only), tissue and cell type	PROK2 DPYD HK3 CFP SIGLEC1 TYMP	2.81e-06	197	89	6	a0f8a992282a6d64890f5574c7c9741fcb38dadd
ToppCell	COVID-19-lung-Capillary_1\|lung / Disease (COVID-19 only), tissue and cell type	FZD4 RNF144B VWF ARHGAP31 ARHGAP29 SEC14L1	2.81e-06	197	89	6	7e86ff9dafcbaaa7464d61484dd48bfeb7eae6e4
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PDLIM3 PDLIM1 SLIT3 CARD16 ALDH1A3 DENND2B	2.81e-06	197	89	6	236a40eb6c08e1d179cf0fb5450b032975c5f6b6
ToppCell	Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_capillary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FZD4 RNF144B VWF PDLIM1 ARHGAP29 SEC14L1	2.81e-06	197	89	6	81718164c9802ee20c860ffbda7e62d5e9a76f16
ToppCell	LA-09._Endothelium_I\|LA / Chamber and Cluster_Paper	RNF144B VWF HMCN1 ARHGAP31 ARHGAP29 SEC14L1	2.81e-06	197	89	6	ab6d1ab586a188597a39854ef980b8955ebcc645
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RNF144B HK3 CFP CARD16 TYMP LYST	2.81e-06	197	89	6	b4f6501c266328439cba4f174e594a6a04a252a1
ToppCell	LV-09._Endothelium_I\|LV / Chamber and Cluster_Paper	RNF144B VWF HMCN1 ARHGAP31 ARHGAP29 SEC14L1	2.81e-06	197	89	6	f9731d4d636e51b94a96805eee6afe9aedc175e3
ToppCell	normal-na-Myeloid-non-classical_monocyte-female\|normal / PBMC cell types (v2) per disease, treatment status, and sex	RNF144B HK3 CFP CARD16 TYMP LYST	2.89e-06	198	89	6	d91bd26e499637949768587603cad3c03dcc56e7
ToppCell	normal-na-Myeloid-non-classical_monocyte\|normal / PBMC cell types (v2) per disease, treatment status, and sex	RNF144B HK3 CFP CARD16 TYMP LYST	2.89e-06	198	89	6	f5a12861e2b8ff8309f3e4d0ad83d4f6860cc616
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-squamous_epithelial_cell-Epi-Squamous\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	TRAF4 FCGBP PDLIM1 DUOX2 ALDH1A3 TACSTD2	2.89e-06	198	89	6	72d91bd0c727ecadc41e023a16c9326158db1b7b
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-squamous_epithelial_cell\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	TRAF4 FCGBP PDLIM1 DUOX2 ALDH1A3 TACSTD2	2.89e-06	198	89	6	441608034c787e55691558a480dcd07e37419138
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	FZD4 VWF HMCN1 PDLIM1 ARHGAP29 TNFRSF10D	2.89e-06	198	89	6	7cddd474416651088a4e08edfc0ac420ff10a5fe
ToppCell	10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	FZD4 VWF HMCN1 PDLIM1 ARHGAP29 AGRN	2.97e-06	199	89	6	0602e2b2aa56d106da63bd342a38bef437b4d496
ToppCell	10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	FZD4 VWF HMCN1 PDLIM1 ARHGAP29 AGRN	2.97e-06	199	89	6	463ba77dc4c85eebb343f29a42c7ac889b0497c9
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16\|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)	RNF144B HK3 CFP CARD16 TYMP LYST	2.97e-06	199	89	6	df946601b295be5419c09befbfa73f4314eef116
ToppCell	Parenchymal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_capillary\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	FZD4 RNF144B VWF PDLIM1 ARHGAP29 SEC14L1	2.97e-06	199	89	6	772b3f60b83e29b958e1e70dadfd9f058ed4cb7c
ToppCell	Parenchymal-10x5prime-Immune_Myeloid-Monocytic-Monocyte_CD16\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	RNF144B HK3 CFP CARD16 TYMP LYST	3.06e-06	200	89	6	83d9aa5b46ae7a71a258b2e44b3251f95bc9a1b7
ToppCell	Bronchial-10x5prime-Immune_Myeloid-Monocytic-Monocyte_CD16\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	RNF144B HK3 CFP CARD16 TYMP LYST	3.06e-06	200	89	6	d39bf03817b76c9dfcbcd868341b51bb8601ea9b
ToppCell	COVID_vent-Myeloid-Monocytic-CD14+_Monocyte\|COVID_vent / Disease condition, Lineage, Cell class and subclass	DPYD HK3 CFP SIGLEC1 TYMP LYST	3.06e-06	200	89	6	e57452b73abb21cb3f645d45523ab93f6bef0243
ToppCell	Parenchymal-10x3prime_v2-Endothelial-Endothelia_vascular\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	FZD4 RNF144B VWF PDLIM1 ARHGAP29 SEC14L1	3.06e-06	200	89	6	6567683f8f534310fecb44a6721909183fdc15ca
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	RNF144B FCGBP HK3 LRCH4 AKAP13 TYMP	3.06e-06	200	89	6	74ceebee9af63f8b3ec5857eff1b662752bc3862
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Myeloid-Monocytic-Nonclassical_Monocyte\|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)	RNF144B HK3 CFP CARD16 TYMP LYST	3.06e-06	200	89	6	97f261d56bc6c55683eb4c42670d00b9a6992a26
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NELL1 EGF SLIT3 ASTN2 DNAI3	5.26e-06	125	89	5	b162a5bfbb8ac5e65e13578fef9de442a9e4fd8b
ToppCell	Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2-Slc17a8.Synpr-Sncg-Yjefn3_(Neuron.Gad1Gad2-Slc17a8.Synpr-Sncg-Yjefn3)-\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	PROK2 FCGBP LOXHD1 KCNA10	9.97e-06	67	89	4	e53dfc288c943656a0b064afe593ea2101d75437
ToppCell	Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2-Slc17a8.Synpr-Sncg-Yjefn3_(Neuron.Gad1Gad2-Slc17a8.Synpr-Sncg-Yjefn3)\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	PROK2 FCGBP LOXHD1 KCNA10	9.97e-06	67	89	4	1841cee311a4b1b802c9e872793435afb730592f
ToppCell	facs-Aorta-Heart-3m-Epithelial-epithelial_cell\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KCNQ5 ADGRB2 MASTL IGSF21 BHMT	1.32e-05	151	89	5	0de76acd1b204345dce7f33be2a1ed9fbe9e6da0
ToppCell	facs-Aorta-Heart-3m-Epithelial-nan\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KCNQ5 ADGRB2 MASTL IGSF21 BHMT	1.32e-05	151	89	5	20b9c8fb966c5d62ff909cc4a4616b109b78cdca
ToppCell	facs-Aorta-Heart-3m-Epithelial\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KCNQ5 ADGRB2 MASTL IGSF21 BHMT	1.32e-05	151	89	5	bee48137d1f5f27a24571a59c835284651d38538
ToppCell	Transplant_Alveoli_and_parenchyma-Epithelial-Type_1_alveolar\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	PROK2 ALDH1A3 ERVW-1 TACSTD2 AGRN	1.74e-05	160	89	5	58ed3a074932ccc951e07868dfdc61b99ae1cc2b
ToppCell	facs-Lung-Endomucin_-18m-Myeloid-Neutrophil\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PROK2 HK3 CFP TACSTD2 LYST	1.80e-05	161	89	5	e227f7b711475624cf80e77f235b1783d88d57b4
ToppCell	facs-Lung-Endomucin_-18m-Myeloid-neutrophil\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PROK2 HK3 CFP TACSTD2 LYST	1.80e-05	161	89	5	8280a029026c272cae9649b27575831b0dd4e242
ToppCell	droplet-Heart-HEART_(LV+RV_ONLY)-30m-Hematologic-fibroblast\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DPYD HK3 FZD5 SLIT3 SIGLEC1	2.27e-05	169	89	5	15a9183c838cc6384d7f5dfeae3d30602964c9b3
ToppCell	facs-Liver-Non-hepatocytes-3m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HK3 ANO6 CFP SIGLEC1 ITGB5	2.27e-05	169	89	5	44d841fd997a6f26104f16cd00223ecce8352f43
ToppCell	390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_5\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	FCGBP PDLIM3 HMCN1 ASTN2 TACSTD2	2.27e-05	169	89	5	d2def7229fe9d6b0c70cfed349ede491c8c137a0
ToppCell	facs-Liver-Non-hepatocytes-3m-Myeloid-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HK3 ANO6 CFP SIGLEC1 ITGB5	2.27e-05	169	89	5	0f5e737b265ba333275a0cd289dab029a1542075
ToppCell	facs-Liver-Non-hepatocytes-3m-Myeloid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HK3 ANO6 CFP SIGLEC1 ITGB5	2.27e-05	169	89	5	aec1b4c7e973a31c53aaea47c2c05d24ce16aa4f
ToppCell	5'-Adult-Appendix-Hematopoietic-Myeloid-Monocytes\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PROK2 LOXHD1 HK3 CFP TYMP	2.33e-05	170	89	5	1c3c03821c90d41de92fef3278f71093a7fd709c
ToppCell	droplet-Kidney-nan-21m-Lymphocytic-B_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDLIM1 DUOX2 CFP SLURP2 IGSF21	2.33e-05	170	89	5	53fd50c9a27d47662fbcbd7e9e9837f72ac448c5
ToppCell	wk_08-11-Hematologic-Meg-ery-Megakaryocyte\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	CATIP LOXHD1 EGF MFSD2B MAP3K5	2.40e-05	171	89	5	9dda25df493766723335851b3c3d89735b6e8051
ToppCell	metastatic_Brain-B_lymphocytes-Undetermined\|B_lymphocytes / Location, Cell class and cell subclass	KCNQ5 ARHGAP31 AKAP13 CFP ACTR3B	2.40e-05	171	89	5	0d14bc9688c427ba2265984987dc3eea195b19eb
ToppCell	AT1-AT2_cells-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	ARHGAP29 ALDH1A3 TACSTD2 AGRN MUC6	2.47e-05	172	89	5	0be41df5d35d818deb7316ac21c9366eb4b7bfd1
ToppCell	facs-Liver-Liver_non-hepato/SCs_st-18m-Myeloid-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HK3 ANO6 CFP SIGLEC1 ITGB5	2.61e-05	174	89	5	3533a47885af453d97739e5576e989d93d31be32
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	NELL1 NELL2 SLIT3 GRM1 IGSF21	2.61e-05	174	89	5	bc978a2148a0261a4f9d1ca5479b707e224566be
ToppCell	facs-Liver-Liver_non-hepato/SCs-18m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HK3 ANO6 CFP SIGLEC1 ITGB5	2.61e-05	174	89	5	dc4298c1d9359f7e37454e9451f889017227d5cf
ToppCell	facs-Liver-Liver_non-hepato/SCs_st-18m-Myeloid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HK3 ANO6 CFP SIGLEC1 ITGB5	2.61e-05	174	89	5	b487c5c46f074a69b9526a2c72daf218f66aa44b
ToppCell	wk_20-22-Hematologic-Myeloid-Promonocyte-like\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	HK3 CFP ERVW-1 TYMP LYST	2.68e-05	175	89	5	654299df246debe0a5b12f0d9568eb828bb94bb9
ToppCell	10x5'v1-week_17-19-Myeloid_macrophage-stroma-erythroid_macrophage\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	MST1 EGFR MYT1 SIGLEC1 MUC6	2.83e-05	177	89	5	b647667da62a91dbe3890820142626e26aa779d2
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	NELL1 DPYD AKAP13 GRM1 IGSF21	2.91e-05	178	89	5	b169aa5eaa51730daaec69c6bc58126be1592a50
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NELL1 EGF HMCN1 ASTN2 GRM1	2.91e-05	178	89	5	4df6218b20c2f076c22346d23260964cc0d73e65
ToppCell	droplet-Lung-LUNG-30m-Endothelial-Artery_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VWF EGF PDLIM3 ARHGAP29 ACTR3B	2.99e-05	179	89	5	a09647750eba9d93c5efc1db3b555fefb5eec7b5
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L5-6_THEMIS_TMEM233\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	NELL1 DPYD SLIT3 AKAP13 GRM1	2.99e-05	179	89	5	747a32460b257fffca30527b56a74720eb9c12e4
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	NELL1 NELL2 SLIT3 GRM1 IGSF21	2.99e-05	179	89	5	065a50952e8703fa07767beb6b73a090bf378ca6
ToppCell	10x5'-lymph-node_spleen-Myeloid_Mac-Intestinal_macrophages\|lymph-node_spleen / Manually curated celltypes from each tissue	HK3 SIGLEC1 TYMP IGSF21 ITGB5	3.07e-05	180	89	5	7be7d7a6906fff6dbdecd9cb013d855aba4eda2a
ToppCell	metastatic_Brain-Myeloid_cells-CD207+CD1a+_LCs\|metastatic_Brain / Location, Cell class and cell subclass	FCGBP MOB3B CARD16 TACSTD2 CBR3	3.07e-05	180	89	5	51727cb66fe7a7709453f7026e0ff3d6c93d5aa5
ToppCell	Control-Endothelial_cells-Capillary_endothelial_cells\|Control / group, cell type (main and fine annotations)	FZD4 ARHGAP31 ARHGAP29 DENND2B SEC14L1	3.07e-05	180	89	5	b043f9ffb9a4cd427a15bebb86a711c7b08866e8
ToppCell	metastatic_Lymph_Node-Myeloid_cells-CD207+CD1a+_LCs\|metastatic_Lymph_Node / Location, Cell class and cell subclass	FCGBP SLIT3 MOB3B TACSTD2 CBR3	3.07e-05	180	89	5	289f8c4b53ffd164fee1f459a9315c0deb5f76d0
ToppCell	COVID-19-Endothelial_cells-Endothelial_cells_(other)\|COVID-19 / group, cell type (main and fine annotations)	FZD4 VWF PDLIM1 ARHGAP29 SEC14L1	3.15e-05	181	89	5	26eb4ee57a70dbf54e096b73129fda9dfda1f6ec
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RNF144B EGFR SLIT3 ARHGAP29 ASTN2	3.15e-05	181	89	5	071f9bb5d39070cdc473d9b0e094d196bc702b56
ToppCell	facs-Liver-Liver_non-hepato/SCs_st-18m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HK3 ANO6 CFP SIGLEC1 ITGB5	3.15e-05	181	89	5	a93df1ba23d5b5f249491d69d12bfc0e274dafcf
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Dendritic\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	CFP CARD16 SIGLEC1 TYMP ITGB5	3.23e-05	182	89	5	9a68d3bd1cc9139de9e9e711c249d47ade826bb1
Drug	ketopantoate	DPYD EGFR TYMP LYST	4.19e-06	29	86	4	CID000000038
Drug	strontium phosphate	VWF EGF SMCP	1.12e-05	12	86	3	CID000159737
Drug	5-ethylbarbituric acid	EGF EGFR	1.41e-05	2	86	2	CID000017292
Drug	5-phenylbarbituric acid	EGF EGFR	1.41e-05	2	86	2	CID000089646
Drug	Vinca-type compound	EGF EGFR	1.41e-05	2	86	2	CID000494342
Drug	PD173952	VWF EGF EGFR	2.29e-05	15	86	3	CID005328733
Drug	5-aza-2'-deoxycytidine	NELL1 FCGBP EGFR NANOG SLIT3 LRCH4 ARHGAP29 DUOX2 TNFRSF10D PMEL ALDH1A3	2.79e-05	638	86	11	CID000016886
Drug	panobinostat	PROK2 RNF144B NELL1 NELL2 EGF PDLIM1 ARHGAP31 FZD5 NANOG SLIT3 ASTN2 ALDH1A3 TACSTD2 IGSF21 ITGB5 CHAC1	3.44e-05	1333	86	16	ctd:C496932
Drug	Camptothecin	RAD51C DPYD LRCH4 AKAP13 AGRN MAP3K5	3.60e-05	163	86	6	ctd:D002166
Drug	Aluminum Silicates	EGF EGFR	4.22e-05	3	86	2	ctd:D000538
Drug	FD137 nitrosourea	EGF EGFR	4.22e-05	3	86	2	ctd:C471268
Drug	Ptpc	HK3 CARD16 TNFRSF10D MAP3K5	5.59e-05	55	86	4	CID003036276
Drug	ZD4190	NELL1 NELL2 EGF	5.66e-05	20	86	3	CID005329032
Drug	5-fluoropyrimidine	DPYD MTHFR TYMP	5.66e-05	20	86	3	CID000069605
Drug	PTK/ZK	VWF EGF EGFR PMEL	6.00e-05	56	86	4	CID000151193
Drug	Proscillaridin A [466-06-8]; Down 200; 7.6uM; MCF7; HT_HG-U133A	ASTN2 TRMT1L CBR3 CHAC1 RBCK1 MAP3K5	6.06e-05	179	86	6	4404_DN
Drug	gemcitabine	DPYD VWF EGF EGFR NANOG ALDH1A3 TYMP	7.38e-05	270	86	7	ctd:C056507
Drug	EGFR/ErbB2 inhibitor	VWF EGFR	8.42e-05	4	86	2	CID009843206
Drug	AC1NR2YL	EGF EGFR	8.42e-05	4	86	2	CID005283757
Drug	AC1NBIRU	IGF2R CARD16 SIGLEC1 TNFRSF10D	8.96e-05	62	86	4	CID004468718
Drug	H-89, Dihydrochloride; Up 200; 0.5uM; PC3; HT_HG-U133A	DPYD TRAF4 IGF2R EGF AKAP13 SEC14L1	9.46e-05	194	86	6	6921_UP
Drug	Nocodazole	EGF NANOG MYT1 TYMP	9.54e-05	63	86	4	ctd:D015739
Drug	Antipyrine [60-80-0]; Down 200; 21.2uM; PC3; HT_HG-U133A	RAD51B EGFR ADGRB2 ASTN2 CHAC1 MAP3K5	9.73e-05	195	86	6	4251_DN
Drug	Carbamazepine [298-46-4]; Down 200; 17uM; PC3; HT_HG-U133A	TRAF4 EGFR ADGRB2 AKAP13 GRM1 ITGB5	9.73e-05	195	86	6	5093_DN
Drug	AC1NQAB4	PROK2 IGF2R SIGLEC1	9.94e-05	24	86	3	CID005192841
Drug	Epivincamine [6835-99-0]; Down 200; 11.2uM; MCF7; HT_HG-U133A	ASTN2 AKAP13 RNF41 LYST DENND2B CHAC1	1.00e-04	196	86	6	2775_DN
Drug	Tenoxicam [59804-37-4]; Down 200; 11.8uM; HL60; HT_HG-U133A	ALMS1 PDLIM1 MTHFR GRM1 CBR3 ITGB5	1.03e-04	197	86	6	2501_DN
Drug	wortmannin from Penicillium funiculosum; Up 200; 0.01uM; HL60; HT_HG-U133A	NELL2 MTHFR MYT1 TNFRSF10D GRM1 MUC6	1.03e-04	197	86	6	2703_UP
Drug	Seneciphylline [480-81-9]; Up 200; 12uM; HL60; HT_HG-U133A	FZD4 RAD51B ALMS1 TNFRSF10D ZNF442 ITGB5	1.03e-04	197	86	6	2140_UP
Drug	Naftopidil dihydrochloride [57149-08-3]; Down 200; 8.6uM; PC3; HT_HG-U133A	TRAF4 MTHFR WDR18 ASTN2 ZNF442 AGRN	1.06e-04	198	86	6	4193_DN
Drug	Nomegestrol acetate [58652-20-3]; Down 200; 10.8uM; PC3; HT_HG-U133A	EGF ASTN2 AKAP13 RNF41 AGRN ITGB5	1.06e-04	198	86	6	6362_DN
Drug	Clonidine hydrochloride [4205-91-8]; Down 200; 15uM; MCF7; HT_HG-U133A	RAD51B MTHFR DENND2B ITGB5 CHAC1 MAP3K5	1.09e-04	199	86	6	6814_DN
Drug	Moroxidine hydrochloride [3160-91-6]; Up 200; 19.2uM; HL60; HG-U133A	FZD4 NELL2 TRAF4 MYT1 MOB3B CHAC1	1.09e-04	199	86	6	2027_UP
Drug	Docetaxel trihydrate	DPYD EGF EGFR TYMP ITGB5 MAP3K5	1.18e-04	202	86	6	CID000003143
Drug	RG 14921	EGF EGFR	1.40e-04	5	86	2	CID000197517
Drug	D 247	EGF EGFR	1.40e-04	5	86	2	CID003048156
Drug	6-quinolinecarbaldehyde	EGF EGFR	1.40e-04	5	86	2	CID000765653
Drug	TAK-165	EGF EGFR	1.40e-04	5	86	2	CID006444692
Drug	Thymine	DPYD TYMP	1.40e-04	5	86	2	ctd:D013941
Drug	netivudine	DPYD TYMP	1.40e-04	5	86	2	CID000055281
Drug	4-(3-chloroanilino)quinazoline	EGF EGFR	1.40e-04	5	86	2	CID000128872
Drug	AC1O3M08	DPYD TYMP	1.40e-04	5	86	2	CID006331955
Drug	NSC-33145	DPYD CARD16 TYMP	1.43e-04	27	86	3	CID000233979
Disease	Colorectal Carcinoma	FZD4 NELL1 DPYD HK3 KCNQ5 KCNA10 EGFR MTHFR GRM1 TYMP ZNF442 IGSF21	9.17e-07	702	86	12	C0009402
Disease	Unipolar Depression	PROK2 NELL1 EGF EGFR MTHFR SLIT3 RNF41 GRM1	9.30e-07	259	86	8	C0041696
Disease	Leukoencephalopathy	DPYD MTHFR TYMP	3.88e-06	11	86	3	C0270612
Disease	Major Depressive Disorder	PROK2 NELL1 EGF EGFR MTHFR SLIT3 RNF41	7.28e-06	243	86	7	C1269683
Disease	Malignant neoplasm of breast	RAD51C RAD51B MST1 DPYD VWF HK3 EGF EGFR MTHFR ARHGAP29 ACCS ASTN2 CFP	1.36e-05	1074	86	13	C0006142
Disease	inflammatory bowel disease (is_implicated_in)	EGFR MTHFR ANO6	2.24e-05	19	86	3	DOID:0050589 (is_implicated_in)
Disease	Hereditary Diffuse Gastric Cancer	DPYD FCGBP EGFR MTHFR ALDH1A3 TYMP MUC6	2.44e-05	293	86	7	C1708349
Disease	Stomach Neoplasms	DPYD FCGBP EGFR MTHFR ALDH1A3 TYMP MUC6	2.66e-05	297	86	7	C0038356
Disease	Malignant neoplasm of stomach	DPYD FCGBP EGFR MTHFR ALDH1A3 TYMP MUC6	2.83e-05	300	86	7	C0024623
Disease	Neoplasm Metastasis	MST1 DPYD EGF EGFR MTHFR TYMP	4.25e-05	217	86	6	C0027627
Disease	Alcoholic Intoxication, Chronic	VWF EGF EGFR MTHFR GRM1 BHMT	1.36e-04	268	86	6	C0001973
Disease	gallbladder cancer (is_marker_for)	DPYD EGF	1.75e-04	7	86	2	DOID:3121 (is_marker_for)
Disease	schizophrenia (is_marker_for)	VWF EGF EGFR	2.90e-04	44	86	3	DOID:5419 (is_marker_for)
Disease	pancreatic cancer (is_implicated_in)	DPYD EGFR MTHFR TYMP	3.29e-04	112	86	4	DOID:1793 (is_implicated_in)
Disease	colon cancer (implicated_via_orthology)	NANOGP8 NANOG	4.54e-04	11	86	2	DOID:219 (implicated_via_orthology)
Disease	Childhood Ataxia with Central Nervous System Hypomyelinization	DPYD MTHFR	7.47e-04	14	86	2	C1858991
Disease	nephroblastoma (is_implicated_in)	IGF2R MTHFR	7.47e-04	14	86	2	DOID:2154 (is_implicated_in)
Disease	Bladder Neoplasm	EGFR MTHFR TYMP IGSF21	7.63e-04	140	86	4	C0005695
Disease	Malignant neoplasm of urinary bladder	EGFR MTHFR TYMP IGSF21	7.83e-04	141	86	4	C0005684
Disease	amino acid measurement	NELL2 VWF ALMS1 MYT1 SLIT3 LRCH4 ASTN2 GRM1	8.19e-04	678	86	8	EFO_0005134
Disease	glycerate measurement	HMCN1 AGRN	8.60e-04	15	86	2	EFO_0021029
Disease	Mammary Carcinoma, Human	RAD51C RAD51B MST1 DPYD EGF EGFR MTHFR	8.68e-04	525	86	7	C4704874
Disease	Mammary Neoplasms, Human	RAD51C RAD51B MST1 DPYD EGF EGFR MTHFR	8.68e-04	525	86	7	C1257931
Disease	Mammary Neoplasms	RAD51C RAD51B MST1 DPYD EGF EGFR MTHFR	8.87e-04	527	86	7	C1458155
Disease	Dermatitis	EGF EGFR	9.81e-04	16	86	2	C0011603
Disease	Breast Carcinoma	RAD51C RAD51B MST1 DPYD EGF EGFR MTHFR	1.00e-03	538	86	7	C0678222
Disease	Colonic Neoplasms	DPYD EGFR MTHFR TYMP	1.04e-03	152	86	4	C0009375
Disease	Malignant tumor of colon	DPYD EGFR MTHFR TYMP	1.22e-03	159	86	4	C0007102
Disease	Endometrial Carcinoma	RNF144B EGFR MTHFR	1.23e-03	72	86	3	C0476089
Disease	Congenital hernia of foramen of Morgagni	IGF2R KCNQ5	1.39e-03	19	86	2	C0265699
Disease	Congenital hernia of foramen of Bochdalek	IGF2R KCNQ5	1.39e-03	19	86	2	C0265700
Disease	ankylosing spondylitis (is_implicated_in)	MTHFR ANO6	1.39e-03	19	86	2	DOID:7147 (is_implicated_in)
Disease	type 1 diabetes mellitus (biomarker_via_orthology)	VWF EGFR	1.39e-03	19	86	2	DOID:9744 (biomarker_via_orthology)
Disease	Congenital diaphragmatic hernia	IGF2R KCNQ5	1.70e-03	21	86	2	C0235833
Disease	Lymphoma, Diffuse	MTHFR BHMT	1.70e-03	21	86	2	C3714542
Disease	Low Grade Lymphoma (neoplasm)	MTHFR BHMT	1.70e-03	21	86	2	C0079747
Disease	Lymphoma, Intermediate-Grade	MTHFR BHMT	1.70e-03	21	86	2	C0079741
Disease	High Grade Lymphoma (neoplasm)	MTHFR BHMT	1.70e-03	21	86	2	C0079740
Disease	Diffuse Mixed-Cell Lymphoma	MTHFR BHMT	1.70e-03	21	86	2	C0079757
Disease	Neutropenia	DPYD MTHFR	1.70e-03	21	86	2	C0027947
Disease	Lymphoma, Undifferentiated	MTHFR BHMT	1.70e-03	21	86	2	C0024306
Disease	Reticulosarcoma	MTHFR BHMT	1.70e-03	21	86	2	C0024302
Disease	Lymphoma, Mixed-Cell	MTHFR BHMT	1.70e-03	21	86	2	C0024304
Disease	Cleft Palate	FZD4 EGF ARHGAP29	1.73e-03	81	86	3	C0008925
Disease	Lymphoma, Non-Hodgkin, Familial	MTHFR BHMT	1.87e-03	22	86	2	C4721532
Disease	transitional cell carcinoma (is_implicated_in)	MTHFR TYMP	1.87e-03	22	86	2	DOID:2671 (is_implicated_in)
Disease	Lymphoma, Small Noncleaved-Cell	MTHFR BHMT	1.87e-03	22	86	2	C0079770
Disease	Parkinson Disease	IGF2R MTHFR MAP3K5	1.99e-03	85	86	3	C0030567
Disease	Cancer of Head	DPYD EGFR	2.22e-03	24	86	2	C0751177
Disease	Head Neoplasms	DPYD EGFR	2.22e-03	24	86	2	C0018675
Disease	Upper Aerodigestive Tract Neoplasms	DPYD EGFR	2.22e-03	24	86	2	C0887900
Disease	migraine disorder, diastolic blood pressure	ASTN2 ITGB5	2.41e-03	25	86	2	EFO_0006336, MONDO_0005277
Disease	Neck Neoplasms	DPYD EGFR	2.41e-03	25	86	2	C0027533
Disease	Cancer of Neck	DPYD EGFR	2.41e-03	25	86	2	C0746787
Disease	coronary artery disease	NELL1 DPYD IGF2R MTHFR DUOX2 ASTN2 AKAP13 DENND2B ITGB5 TLCD5	2.47e-03	1194	86	10	EFO_0001645
Disease	dihomo-gamma-linolenic acid measurement	NANOGP8 ANO6	2.81e-03	27	86	2	EFO_0007763
Disease	thrombocytopenia (is_implicated_in)	MTHFR MASTL	2.81e-03	27	86	2	DOID:1588 (is_implicated_in)

Protein segments in the cluster

Peptide	Gene	Start	Entry
SPSVPLVIGCAVSCM	ADGRB2	931	O60241
ASGKPVAATMCIGPE	BHMT	176	Q93088
PPLCIAQCGGTVEEM	CSMD2	1961	Q7Z408
APTTCLGPTCMQDLG	ACCS	11	Q96QU6
MAGSLPPCVVDCGTG	ACTR3B	1	Q9P1U1
CLETVASNPGMPVKC	MASTL	271	Q96GX5
QMTGLCSCKPGVAGP	AGRN	861	O00468
SIPVVGPISCSQCMK	AKAP13	1796	Q12802
QSPRGMGCKPEAVCS	ALMS1	2561	Q8TCU4
CCGNTMVLKPAEQTP	ALDH1A3	196	P47895
PLGLTCGMVCPTSDL	DPYD	121	Q12882
KNLIGTFACVCPPGM	FBN3	2226	Q75N90
EGVMTGPLLQSCCAP	DNAI3	701	Q8IWG1
SMIDIVCCPTPFLVG	DENND2B	936	P78524
SSGCVCPEELKPMKD	ASTN2	676	O75129
ITGPPGCGKTQFCIM	RAD51B	106	O15315
PLMKTTEICGAPGVG	RAD51C	116	O43502
CRKMGVPEADLCSPS	LRCH4	611	O75427
FCTERTCPVMSGGPK	MOB3B	81	Q86TA1
REGCGSPITCPDMVC	RNF144B	66	Q7Z419
VCHPDIGGKIIMCPQ	ANO6	336	Q4KMQ2
APTCQMLATGVACVP	MUC6	786	Q6W4X9
MLATGVACVPTKCEP	MUC6	791	Q6W4X9
KACTDMGITCPIVPG	MTHFR	241	P42898
CCGLETKPEVSPLNM	SMCP	71	P49901
VPGETGLPGSMKDTC	MIS18BP1	326	Q6P0N0
CDCPGLVMPSFVSTK	LSG1	436	Q9H089
MKLVESSGCPALDCP	NELL2	366	Q99435
MPCLAPIAAKVGSVG	MGA	3011	Q8IWI9
GCTFINKPTRPGCEM	RBCK1	201	Q9BYM8
GGETLLSVCPMVPKD	KCNQ5	811	Q9NR82
VDAPSLGKCMTFPCG	LOXHD1	1056	Q8IVV2
SCGPPGMTKNVEKAC	DUOX2	1516	Q9NRD8
ASDCKESSPMPVICG	NANOG	16	Q9H9S0
AGLCILMVGSTPKTP	MFSD2B	471	A6NFX1
VSPCPVTCGLGQTME	CFP	266	P27918
VLPVGTMPEGTIVCC	RPL8	101	P62917
TMPEGTIVCCLEEKP	RPL8	106	P62917
TMMGCEPGVRPCEVG	HK3	226	P52790
TEPGAFGEMCEKCPT	ITGB5	616	P18084
CRGGVLVKITEMCPP	NELL1	356	Q92832
GDITVMECKTSGIPP	HMCN1	716	Q96RW7
GDKMCPGCSDPVQRI	CBLL1	141	Q75N03
RICTPMGKLGDSCHP	PROK2	56	Q9HC23
DMCPTTPGGKIVGTL	KCNA10	426	Q16322
MCSIGVVDQGCFPKP	ARHGAP29	896	Q52LW3
CTEKINIPIGPCGGM	FZD4	106	Q9ULV1
NIPIGPCGGMCLSVK	FZD4	111	Q9ULV1
PVCQEITVPMCRGIG	FZD5	31	Q13467
IDGPHCVKTCPAGVM	EGFR	586	P00533
FTLVCIVSGGKPAPM	IGSF21	166	Q96ID5
MGVPVCPPASSKCIN	EGF	876	P01133
VLSPVEPSCEGMQCA	FCGBP	436	Q9Y6R7
IVDAVGTMLPCFCPT	CHAC1	201	Q9BUX1
GSPGCCIITKMPILR	CATIP	261	Q7Z7H3
GICCCMDPKSVIIPL	LYST	581	Q99698
CCPGPVKTDMDGKDS	CBR3	226	O75828
PVAKMVCGPSGSQLV	MST1	556	P26927
PTGMDCKLVGPETLC	FAM221A	61	A4D161
LCPGHVGLCDAMKPI	GRM1	431	Q13255
KRPVTCEQGCGLEMP	RNF41	111	Q9H4P4
CMCEVPEGGLVPKSL	SEC14L1	491	Q92503
MALPPGTTGVKDCVF	SPACA4	11	Q8TDM5
AMPTCSSPEGRIKLC	CARD16	101	Q5EG05
MGSLEKAGPVSPGCV	PARP10	421	Q53GL7
KLPMCDKCGTGIVGV	PDLIM1	256	O00151
SLGCTIIEMATGKPP	MAP3K5	866	Q99683
GTMPVCGTILGKPAS	IGF2R	971	P11717
MHGVPCPAGAAVCKV	IGF2R	1701	P11717
MINPSCPGGLGVTVC	ERVW-1	91	Q9UQF0
LPCNCHGSMPGKTAI	TRMT1L	511	Q7Z2T5
SGPVVQTMYKACPCG	TGIF2LY	146	Q8IUE0
CPTNKMTVCSPDGPG	TACSTD2	36	P09758
LPSKCIPMICAGHEE	IQCA1L	386	A6NCM1
ESDCKESSPMPVICG	NANOGP8	16	Q6NSW7
MPLCDKCGSGIVGAV	PDLIM3	291	Q53GG5
KIMCPGPVTCLTASP	WDR18	76	Q9BV38
PKEACMEISSPGCQP	PMEL	521	P40967
KMCHIGCPDIPSLGL	SLURP2	66	P0DP57
GCPRGMVKVSNCTPR	TNFRSF10D	161	Q9UBN6
SKVPIMECRGGCGPQ	SLIT3	1471	O75094
GGPTCSVIAHMCPEI	UGDH	16	O60701
GACLLFCEMVSPTPK	TLCD5	176	Q6ZRR5
SMGCVSGCLCPPGMV	VWF	801	P04275
CLAEGGKIMKIPGTC	VWF	2701	P04275
MVGILPLCCSGCVPS	KRT10-AS1	1	Q8N816
KSSPVDATAPCMCEG	ARHGAP31	1271	Q2M1Z3
CGGCSPRMKVTKAPN	SIGLEC1	656	Q9BZZ2
CGKPMREPVQVSTCG	TRAF4	21	Q9BUZ4
SGFSMPGKPGVVCVE	RWDD2B	216	P57060
ELGSKVPFCPMVGSE	RUVBL1	86	Q9Y265
PGVDPCKSSVCGEIM	ZNF442	111	Q9H7R0
PALAACGCKVPMISG	TYMP	131	P19971
MKCPVPGCVGLGHIS	MYT1	891	Q01538